Multiplex immunoassays support vaccine development, immunology research, and other key applications within immunology

[thumbnail]

IMMUNOLOGY2023: The Largest Conference of Immunology Professionals

The Luminex team was thrilled to attend IMMUNOLOGY2023, the annual meeting of the American Association of Immunologists. Held this year in Washington, D.C., the event is the largest conference dedicated to immunology research in the world, bringing together thousands of experts from academia, industry, and government to share the latest updates in immunology research, vaccine development, looming public health threats, and more.

Distinguished Speakers and Presentations at IMMUNOLOGY2023

The meeting is famous for its highly-regarded key opinion leaders and presentations, and the 2023 show did not disappoint. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, gave a lecture about what experts within the field can learn from the COVID-19 pandemic to better inform future pandemic preparedness efforts. Two other distinguished lectures, one from Douglas Green at St. Jude Children’s Research Hospital and the other from Leslie Berg at the University of Colorado, focused on T cells — it’s encouraging to see how much progress has been made in understanding the role of these cells and how we can utilize them to deliver better patient care.

Workshop Presentations: Harnessing Multiplexing for Immunology Studies

Immunology is a popular application for users of xMAP^® Technology. Whether you’re measuring cytokine response or detecting the full range of antibodies relevant to a potential infection, having a bead-based multiplex assay to support your research provides an enormous advantage. Immunologists were among the earliest groups of scientists to see the value of stepping away from single-plex ELISAs to adopt our customizable, bead-based multiplex technology to generate more data while using minimal sample volumes.

Such was the focus for two workshop presentations at the conference. In one, Anthony Saporita from MilliporeSigma spoke about xMAP Technology and how multiplexing kits allow for lot-to-lot consistency, sensitivity, flexibility, and reproducible sample measurement. He also highlighted the benefits of using extremely sensitive assays for the detection of low-abundance cytokines. In a separate talk, Luminex’s own Joanna Dragich gave a presentation on the power of xMAP multiplexing technology for vaccine development applications, from drug product characterization to serotype monitoring, lot-release testing, and post-market surveillance. She also spoke about how scientists may best approach designing custom multiplex assays for vaccine development.

Looking Ahead: IMMUNOLOGY2024 in Chicago, IL

If you attended IMMUNOLOGY2023, we hope you found it as illuminating as we did. We’re already looking forward to next year’s event in Chicago, IL!

For Research Use Only. Not for use in diagnostic procedures.